Global Rasagiline Tablet Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Rasagiline Tablet Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Rasagiline Tablet Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 0.5 mg/Pcs
1.2.3 1 mg/Pcs
1.3 Market Segment by Application
1.3.1 Global Rasagiline Tablet Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Rasagiline Tablet Market Size (2017-2028)
2.1.1 Global Rasagiline Tablet Revenue (2017-2028)
2.1.2 Global Rasagiline Tablet Sales (2017-2028)
2.2 Global Rasagiline Tablet Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Rasagiline Tablet Sales by Regions (2017-2022)
2.2.2 Global Rasagiline Tablet Revenue by Regions (2017-2022)
2.3 Global Rasagiline Tablet Market Size Forecast by Region
2.3.1 Global Rasagiline Tablet Sales Forecast by Region (2023-2028)
2.3.2 Global Rasagiline Tablet Revenue Forecast by Region (2023-2028)
2.4 Global Top Rasagiline Tablet Regions (Countries) Ranking by Market Size
2.5 Rasagiline Tablet Market Dynamics
2.5.1 Rasagiline Tablet Market Trends
2.5.2 Rasagiline Tablet Market Drivers
2.5.3 Rasagiline Tablet Market Challenges
2.5.4 Rasagiline Tablet Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Rasagiline Tablet Manufacturers by Sales (2017-2022)
3.1.1 Global Rasagiline Tablet Sales by Manufacturers (2017-2022)
3.1.2 Global Rasagiline Tablet Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Rasagiline Tablet Sales in 2021
3.2 Global Top Manufacturers Rasagiline Tablet by Revenue
3.2.1 Global Rasagiline Tablet Revenue by Manufacturers (2017-2022)
3.2.2 Top Rasagiline Tablet Manufacturers Covered: Ranking by Revenue
3.2.3 Global Rasagiline Tablet Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Rasagiline Tablet Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rasagiline Tablet as of 2021)
3.4 Global Rasagiline Tablet Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Rasagiline Tablet Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Rasagiline Tablet Market
3.7 Key Manufacturers Rasagiline Tablet Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Rasagiline Tablet Market Size by Type
4.1 Global Rasagiline Tablet Historic Market Review by Type (2017-2022)
4.1.1 Global Rasagiline Tablet Sales Market Share by Type (2017-2022)
4.1.2 Global Rasagiline Tablet Revenue Market Share by Type (2017-2022)
4.1.3 Rasagiline Tablet Price by Type (2017-2022)
4.2 Global Rasagiline Tablet Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Rasagiline Tablet Sales Forecast by Type (2023-2028)
4.2.2 Global Rasagiline Tablet Revenue Forecast by Type (2023-2028)
4.2.3 Rasagiline Tablet Price Forecast by Type (2023-2028)
5 Global Rasagiline Tablet Market Size by Application
5.1 Global Rasagiline Tablet Historic Market Review by Application (2017-2022)
5.1.1 Global Rasagiline Tablet Sales Market Share by Application (2017-2022)
5.1.2 Global Rasagiline Tablet Revenue Market Share by Application (2017-2022)
5.1.3 Rasagiline Tablet Price by Application (2017-2022)
5.2 Global Rasagiline Tablet Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Rasagiline Tablet Sales Forecast by Application (2023-2028)
5.2.2 Global Rasagiline Tablet Revenue Forecast by Application (2023-2028)
5.2.3 Rasagiline Tablet Price Forecast by Application (2023-2028)
6 North America
6.1 North America Rasagiline Tablet Sales Breakdown by Company
6.1.1 North America Rasagiline Tablet Sales by Company (2017-2022)
6.1.2 North America Rasagiline Tablet Revenue by Company (2017-2022)
6.2 North America Rasagiline Tablet Market Size by Type
6.2.1 North America Rasagiline Tablet Sales by Type (2017-2028)
6.2.2 North America Rasagiline Tablet Revenue by Type (2017-2028)
6.3 North America Rasagiline Tablet Market Size by Application
6.3.1 North America Rasagiline Tablet Sales by Application (2017-2028)
6.3.2 North America Rasagiline Tablet Revenue by Application (2017-2028)
6.4 North America Rasagiline Tablet Market Size by Country
6.4.1 North America Rasagiline Tablet Sales by Country (2017-2028)
6.4.2 North America Rasagiline Tablet Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Rasagiline Tablet Sales Breakdown by Company
7.1.1 Europe Rasagiline Tablet Sales by Company (2017-2022)
7.1.2 Europe Rasagiline Tablet Revenue by Company (2017-2022)
7.2 Europe Rasagiline Tablet Market Size by Type
7.2.1 Europe Rasagiline Tablet Sales by Type (2017-2028)
7.2.2 Europe Rasagiline Tablet Revenue by Type (2017-2028)
7.3 Europe Rasagiline Tablet Market Size by Application
7.3.1 Europe Rasagiline Tablet Sales by Application (2017-2028)
7.3.2 Europe Rasagiline Tablet Revenue by Application (2017-2028)
7.4 Europe Rasagiline Tablet Market Size by Country
7.4.1 Europe Rasagiline Tablet Sales by Country (2017-2028)
7.4.2 Europe Rasagiline Tablet Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rasagiline Tablet Sales Breakdown by Company
8.1.1 Asia Pacific Rasagiline Tablet Sales by Company (2017-2022)
8.1.2 Asia Pacific Rasagiline Tablet Revenue by Company (2017-2022)
8.2 Asia Pacific Rasagiline Tablet Market Size by Type
8.2.1 Asia Pacific Rasagiline Tablet Sales by Type (2017-2028)
8.2.2 Asia Pacific Rasagiline Tablet Revenue by Type (2017-2028)
8.3 Asia Pacific Rasagiline Tablet Market Size by Application
8.3.1 Asia Pacific Rasagiline Tablet Sales by Application (2017-2028)
8.3.2 Asia Pacific Rasagiline Tablet Revenue by Application (2017-2028)
8.4 Asia Pacific Rasagiline Tablet Market Size by Region
8.4.1 Asia Pacific Rasagiline Tablet Sales by Region
8.4.2 Asia Pacific Rasagiline Tablet Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Rasagiline Tablet Sales Breakdown by Company
9.1.1 Latin America Rasagiline Tablet Sales by Company (2017-2022)
9.1.2 Latin America Rasagiline Tablet Revenue by Company (2017-2022)
9.2 Latin America Rasagiline Tablet Market Size by Type
9.2.1 Latin America Rasagiline Tablet Sales by Type (2017-2028)
9.2.2 Latin America Rasagiline Tablet Revenue by Type (2017-2028)
9.3 Latin America Rasagiline Tablet Market Size by Application
9.3.1 Latin America Rasagiline Tablet Sales by Application (2017-2028)
9.3.2 Latin America Rasagiline Tablet Revenue by Application (2017-2028)
9.4 Latin America Rasagiline Tablet Market Size by Country
9.4.1 Latin America Rasagiline Tablet Sales by Country (2017-2028)
9.4.2 Latin America Rasagiline Tablet Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rasagiline Tablet Sales Breakdown by Company
10.1.1 Middle East and Africa Rasagiline Tablet Sales by Company (2017-2022)
10.1.2 Middle East and Africa Rasagiline Tablet Revenue by Company (2017-2022)
10.2 Middle East and Africa Rasagiline Tablet Market Size by Type
10.2.1 Middle East and Africa Rasagiline Tablet Sales by Type (2017-2028)
10.2.2 Middle East and Africa Rasagiline Tablet Revenue by Type (2017-2028)
10.3 Middle East and Africa Rasagiline Tablet Market Size by Application
10.3.1 Middle East and Africa Rasagiline Tablet Sales by Application (2017-2028)
10.3.2 Middle East and Africa Rasagiline Tablet Revenue by Application (2017-2028)
10.4 Middle East and Africa Rasagiline Tablet Market Size by Country
10.4.1 Middle East and Africa Rasagiline Tablet Sales by Country (2017-2028)
10.4.2 Middle East and Africa Rasagiline Tablet Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Corporation Information
11.1.2 Teva Pharmaceutical Overview
11.1.3 Teva Pharmaceutical Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Teva Pharmaceutical Rasagiline Tablet Products and Services
11.1.5 Teva Pharmaceutical Rasagiline Tablet SWOT Analysis
11.1.6 Teva Pharmaceutical Recent Developments
11.2 Lundbeck
11.2.1 Lundbeck Corporation Information
11.2.2 Lundbeck Overview
11.2.3 Lundbeck Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Lundbeck Rasagiline Tablet Products and Services
11.2.5 Lundbeck Rasagiline Tablet SWOT Analysis
11.2.6 Lundbeck Recent Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Corporation Information
11.3.2 Sun Pharmaceutical Overview
11.3.3 Sun Pharmaceutical Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Sun Pharmaceutical Rasagiline Tablet Products and Services
11.3.5 Sun Pharmaceutical Rasagiline Tablet SWOT Analysis
11.3.6 Sun Pharmaceutical Recent Developments
11.4 Apotex
11.4.1 Apotex Corporation Information
11.4.2 Apotex Overview
11.4.3 Apotex Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Apotex Rasagiline Tablet Products and Services
11.4.5 Apotex Rasagiline Tablet SWOT Analysis
11.4.6 Apotex Recent Developments
11.5 Taj Pharma
11.5.1 Taj Pharma Corporation Information
11.5.2 Taj Pharma Overview
11.5.3 Taj Pharma Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Taj Pharma Rasagiline Tablet Products and Services
11.5.5 Taj Pharma Rasagiline Tablet SWOT Analysis
11.5.6 Taj Pharma Recent Developments
11.6 Mylan
11.6.1 Mylan Corporation Information
11.6.2 Mylan Overview
11.6.3 Mylan Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Mylan Rasagiline Tablet Products and Services
11.6.5 Mylan Rasagiline Tablet SWOT Analysis
11.6.6 Mylan Recent Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Corporation Information
11.7.2 Takeda Pharmaceutical Overview
11.7.3 Takeda Pharmaceutical Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Takeda Pharmaceutical Rasagiline Tablet Products and Services
11.7.5 Takeda Pharmaceutical Rasagiline Tablet SWOT Analysis
11.7.6 Takeda Pharmaceutical Recent Developments
11.8 Sandoz
11.8.1 Sandoz Corporation Information
11.8.2 Sandoz Overview
11.8.3 Sandoz Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Sandoz Rasagiline Tablet Products and Services
11.8.5 Sandoz Rasagiline Tablet SWOT Analysis
11.8.6 Sandoz Recent Developments
11.9 Intas Pharmaceuticals
11.9.1 Intas Pharmaceuticals Corporation Information
11.9.2 Intas Pharmaceuticals Overview
11.9.3 Intas Pharmaceuticals Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Intas Pharmaceuticals Rasagiline Tablet Products and Services
11.9.5 Intas Pharmaceuticals Rasagiline Tablet SWOT Analysis
11.9.6 Intas Pharmaceuticals Recent Developments
11.10 Natco Pharma
11.10.1 Natco Pharma Corporation Information
11.10.2 Natco Pharma Overview
11.10.3 Natco Pharma Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Natco Pharma Rasagiline Tablet Products and Services
11.10.5 Natco Pharma Rasagiline Tablet SWOT Analysis
11.10.6 Natco Pharma Recent Developments
11.11 Ajanta Pharma
11.11.1 Ajanta Pharma Corporation Information
11.11.2 Ajanta Pharma Overview
11.11.3 Ajanta Pharma Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Ajanta Pharma Rasagiline Tablet Products and Services
11.11.5 Ajanta Pharma Recent Developments
11.12 Orchid Pharma
11.12.1 Orchid Pharma Corporation Information
11.12.2 Orchid Pharma Overview
11.12.3 Orchid Pharma Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Orchid Pharma Rasagiline Tablet Products and Services
11.12.5 Orchid Pharma Recent Developments
11.13 Alkem Laboratories
11.13.1 Alkem Laboratories Corporation Information
11.13.2 Alkem Laboratories Overview
11.13.3 Alkem Laboratories Rasagiline Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Alkem Laboratories Rasagiline Tablet Products and Services
11.13.5 Alkem Laboratories Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Rasagiline Tablet Value Chain Analysis
12.2 Rasagiline Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rasagiline Tablet Production Mode & Process
12.4 Rasagiline Tablet Sales and Marketing
12.4.1 Rasagiline Tablet Sales Channels
12.4.2 Rasagiline Tablet Distributors
12.5 Rasagiline Tablet Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Rasagiline Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.5 mg/Pcs
Table 3. Major Manufacturers of 1 mg/Pcs
Table 4. Global Rasagiline Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Rasagiline Tablet Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Rasagiline Tablet Sales by Region (2017-2022) & (M Pcs)
Table 7. Global Rasagiline Tablet Sales Market Share by Region (2017-2022)
Table 8. Global Rasagiline Tablet Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Rasagiline Tablet Revenue Market Share by Region (2017-2022)
Table 10. Global Rasagiline Tablet Sales Forecast by Region (2023-2028) & (M Pcs)
Table 11. Global Rasagiline Tablet Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Rasagiline Tablet Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Rasagiline Tablet Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Rasagiline Tablet Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Rasagiline Tablet Market Trends
Table 16. Rasagiline Tablet Market Drivers
Table 17. Rasagiline Tablet Market Challenges
Table 18. Rasagiline Tablet Market Restraints
Table 19. Global Rasagiline Tablet Sales by Manufacturers (2017-2022) & (M Pcs)
Table 20. Global Rasagiline Tablet Sales Share by Manufacturers (2017-2022)
Table 21. Global Rasagiline Tablet Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Rasagiline Tablet Manufacturers by Revenue (US$ Million) in 2021
Table 23. Rasagiline Tablet Revenue Share by Manufacturers (2017-2022)
Table 24. Global Rasagiline Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rasagiline Tablet as of 2021)
Table 26. Key Manufacturers Rasagiline Tablet Average Selling Price (ASP) & (2017-2022) & (USD/K Pcs)
Table 27. Key Manufacturers Rasagiline Tablet Plants/Factories Distribution
Table 28. Key Manufacturers Rasagiline Tablet Area Served
Table 29. Date of Key Manufacturers Enter into Rasagiline Tablet Market
Table 30. Key Manufacturers Rasagiline Tablet Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Rasagiline Tablet Sales (M Pcs) by Type (2017-2022)
Table 33. Global Rasagiline Tablet Sales Share by Type (2017-2022)
Table 34. Global Rasagiline Tablet Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Rasagiline Tablet Price (M Pcs) by Type (2017-2022)
Table 36. Global Rasagiline Tablet Sales (M Pcs) by Type (2023-2028)
Table 37. Global Rasagiline Tablet Sales Share by Type (2023-2028)
Table 38. Global Rasagiline Tablet Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Rasagiline Tablet Revenue Share by Type (2023-2028)
Table 40. Global Rasagiline Tablet Price (M Pcs) by Type (2023-2028)
Table 41. Global Rasagiline Tablet Sales (M Pcs) by Application (2017-2022)
Table 42. Global Rasagiline Tablet Sales Share by Application (2017-2022)
Table 43. Global Rasagiline Tablet Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Rasagiline Tablet Price (M Pcs) by Application (2017-2022)
Table 45. Global Rasagiline Tablet Sales (M Pcs) by Application (2023-2028)
Table 46. Global Rasagiline Tablet Sales Share by Application (2023-2028)
Table 47. Global Rasagiline Tablet Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Rasagiline Tablet Revenue Share by Application (2023-2028)
Table 49. Global Rasagiline Tablet Price (M Pcs) by Application (2023-2028)
Table 50. North America Rasagiline Tablet Sales by Company (2017-2022) & (M Pcs)
Table 51. North America Rasagiline Tablet Sales Market Share by Company (2017-2022)
Table 52. North America Rasagiline Tablet Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Rasagiline Tablet Revenue Market Share by Company (2017-2022)
Table 54. North America Rasagiline Tablet Sales by Type (2017-2022) & (M Pcs)
Table 55. North America Rasagiline Tablet Sales by Type (2023-2028) & (M Pcs)
Table 56. North America Rasagiline Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Rasagiline Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Rasagiline Tablet Sales by Application (2017-2022) & (M Pcs)
Table 59. North America Rasagiline Tablet Sales by Application (2023-2028) & (M Pcs)
Table 60. North America Rasagiline Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Rasagiline Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Rasagiline Tablet Sales by Country (2017-2022) & (M Pcs)
Table 63. North America Rasagiline Tablet Sales by Country (2023-2028) & (M Pcs)
Table 64. North America Rasagiline Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Rasagiline Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Rasagiline Tablet Sales by Company (2017-2022) & (M Pcs)
Table 67. Europe Rasagiline Tablet Sales Market Share by Company (2017-2022)
Table 68. Europe Rasagiline Tablet Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Rasagiline Tablet Revenue Market Share by Company (2017-2022)
Table 70. Europe Rasagiline Tablet Sales by Type (2017-2022) & (M Pcs)
Table 71. Europe Rasagiline Tablet Sales by Type (2023-2028) & (M Pcs)
Table 72. Europe Rasagiline Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Rasagiline Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Rasagiline Tablet Sales by Application (2017-2022) & (M Pcs)
Table 75. Europe Rasagiline Tablet Sales by Application (2023-2028) & (M Pcs)
Table 76. Europe Rasagiline Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Rasagiline Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Rasagiline Tablet Sales by Country (2017-2022) & (M Pcs)
Table 79. Europe Rasagiline Tablet Sales by Country (2023-2028) & (M Pcs)
Table 80. Europe Rasagiline Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Rasagiline Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Rasagiline Tablet Sales by Company (2017-2022) & (M Pcs)
Table 83. Asia Pacific Rasagiline Tablet Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Rasagiline Tablet Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Rasagiline Tablet Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Rasagiline Tablet Sales by Type (2017-2022) & (M Pcs)
Table 87. Asia Pacific Rasagiline Tablet Sales by Type (2023-2028) & (M Pcs)
Table 88. Asia Pacific Rasagiline Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Rasagiline Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Rasagiline Tablet Sales by Application (2017-2022) & (M Pcs)
Table 91. Asia Pacific Rasagiline Tablet Sales by Application (2023-2028) & (M Pcs)
Table 92. Asia Pacific Rasagiline Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Rasagiline Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Rasagiline Tablet Sales by Region (2017-2022) & (M Pcs)
Table 95. Asia Pacific Rasagiline Tablet Sales by Region (2023-2028) & (M Pcs)
Table 96. Asia Pacific Rasagiline Tablet Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Rasagiline Tablet Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Rasagiline Tablet Sales by Company (2017-2022) & (M Pcs)
Table 99. Latin America Rasagiline Tablet Sales Market Share by Company (2017-2022)
Table 100. Latin America Rasagiline Tablet Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Rasagiline Tablet Revenue Market Share by Company (2017-2022)
Table 102. Latin America Rasagiline Tablet Sales by Type (2017-2022) & (M Pcs)
Table 103. Latin America Rasagiline Tablet Sales by Type (2023-2028) & (M Pcs)
Table 104. Latin America Rasagiline Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Rasagiline Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Rasagiline Tablet Sales by Application (2017-2022) & (M Pcs)
Table 107. Latin America Rasagiline Tablet Sales by Application (2023-2028) & (M Pcs)
Table 108. Latin America Rasagiline Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Rasagiline Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Rasagiline Tablet Sales by Country (2017-2022) & (M Pcs)
Table 111. Latin America Rasagiline Tablet Sales by Country (2023-2028) & (M Pcs)
Table 112. Latin America Rasagiline Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Rasagiline Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Rasagiline Tablet Sales by Company (2017-2022) & (M Pcs)
Table 115. Middle East and Africa Rasagiline Tablet Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Rasagiline Tablet Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Rasagiline Tablet Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Rasagiline Tablet Sales by Type (2017-2022) & (M Pcs)
Table 119. Middle East and Africa Rasagiline Tablet Sales by Type (2023-2028) & (M Pcs)
Table 120. Middle East and Africa Rasagiline Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Rasagiline Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Rasagiline Tablet Sales by Application (2017-2022) & (M Pcs)
Table 123. Middle East and Africa Rasagiline Tablet Sales by Application (2023-2028) & (M Pcs)
Table 124. Middle East and Africa Rasagiline Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Rasagiline Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Rasagiline Tablet Sales by Country (2017-2022) & (M Pcs)
Table 127. Middle East and Africa Rasagiline Tablet Sales by Country (2023-2028) & (M Pcs)
Table 128. Middle East and Africa Rasagiline Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Rasagiline Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 130. Teva Pharmaceutical Corporation Information
Table 131. Teva Pharmaceutical Description and Overview
Table 132. Teva Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 133. Teva Pharmaceutical Rasagiline Tablet Product and Services
Table 134. Teva Pharmaceutical Rasagiline Tablet SWOT Analysis
Table 135. Teva Pharmaceutical Recent Developments
Table 136. Lundbeck Corporation Information
Table 137. Lundbeck Description and Overview
Table 138. Lundbeck Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 139. Lundbeck Rasagiline Tablet Product and Services
Table 140. Lundbeck Rasagiline Tablet SWOT Analysis
Table 141. Lundbeck Recent Developments
Table 142. Sun Pharmaceutical Corporation Information
Table 143. Sun Pharmaceutical Description and Overview
Table 144. Sun Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 145. Sun Pharmaceutical Rasagiline Tablet Product and Services
Table 146. Sun Pharmaceutical Rasagiline Tablet SWOT Analysis
Table 147. Sun Pharmaceutical Recent Developments
Table 148. Apotex Corporation Information
Table 149. Apotex Description and Overview
Table 150. Apotex Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 151. Apotex Rasagiline Tablet Product and Services
Table 152. Apotex Rasagiline Tablet SWOT Analysis
Table 153. Apotex Recent Developments
Table 154. Taj Pharma Corporation Information
Table 155. Taj Pharma Description and Overview
Table 156. Taj Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 157. Taj Pharma Rasagiline Tablet Product and Services
Table 158. Taj Pharma Rasagiline Tablet SWOT Analysis
Table 159. Taj Pharma Recent Developments
Table 160. Mylan Corporation Information
Table 161. Mylan Description and Overview
Table 162. Mylan Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 163. Mylan Rasagiline Tablet Product and Services
Table 164. Mylan Rasagiline Tablet SWOT Analysis
Table 165. Mylan Recent Developments
Table 166. Takeda Pharmaceutical Corporation Information
Table 167. Takeda Pharmaceutical Description and Overview
Table 168. Takeda Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 169. Takeda Pharmaceutical Rasagiline Tablet Product and Services
Table 170. Takeda Pharmaceutical Rasagiline Tablet SWOT Analysis
Table 171. Takeda Pharmaceutical Recent Developments
Table 172. Sandoz Corporation Information
Table 173. Sandoz Description and Overview
Table 174. Sandoz Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 175. Sandoz Rasagiline Tablet Product and Services
Table 176. Sandoz Rasagiline Tablet SWOT Analysis
Table 177. Sandoz Recent Developments
Table 178. Intas Pharmaceuticals Corporation Information
Table 179. Intas Pharmaceuticals Description and Overview
Table 180. Intas Pharmaceuticals Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 181. Intas Pharmaceuticals Rasagiline Tablet Product and Services
Table 182. Intas Pharmaceuticals Rasagiline Tablet SWOT Analysis
Table 183. Intas Pharmaceuticals Recent Developments
Table 184. Natco Pharma Corporation Information
Table 185. Natco Pharma Description and Overview
Table 186. Natco Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 187. Natco Pharma Rasagiline Tablet Product and Services
Table 188. Natco Pharma Rasagiline Tablet SWOT Analysis
Table 189. Natco Pharma Recent Developments
Table 190. Ajanta Pharma Corporation Information
Table 191. Ajanta Pharma Description and Overview
Table 192. Ajanta Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 193. Ajanta Pharma Rasagiline Tablet Product and Services
Table 194. Ajanta Pharma Recent Developments
Table 195. Orchid Pharma Corporation Information
Table 196. Orchid Pharma Description and Overview
Table 197. Orchid Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 198. Orchid Pharma Rasagiline Tablet Product and Services
Table 199. Orchid Pharma Recent Developments
Table 200. Alkem Laboratories Corporation Information
Table 201. Alkem Laboratories Description and Overview
Table 202. Alkem Laboratories Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Pcs) and Gross Margin (2017-2022)
Table 203. Alkem Laboratories Rasagiline Tablet Product and Services
Table 204. Alkem Laboratories Recent Developments
Table 205. Key Raw Materials Lists
Table 206. Raw Materials Key Suppliers Lists
Table 207. Rasagiline Tablet Distributors List
Table 208. Rasagiline Tablet Customers List
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources
List of Figures
Figure 1. Rasagiline Tablet Product Picture
Figure 2. Global Rasagiline Tablet Sales Market Share by Type in 2021 & 2028
Figure 3. 0.5 mg/Pcs Product Picture
Figure 4. 1 mg/Pcs Product Picture
Figure 5. Global Rasagiline Tablet Sales Market Share by Application in 2021 & 2028
Figure 6. Under 40 Years Old Use Case
Figure 7. 40-65 Years Old Use Case
Figure 8. Above 65 Years Old Use Case
Figure

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs